VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TRNS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TRNSTranscat, Inc.
$91.28$853M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTRNSFinancials

Transcat, Inc. (TRNS) Financials

30Y historyFree accessUpdated daily

Despite achieving 15.8% revenue growth in 2025Q4, operating margins have compressed to 3.6% as rising SG&A expenses of $27.6M continue to outpace top-line expansion.

TRNS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricMar'26Mar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'04Mar'03Mar'02Mar'01Mar'00Mar'99Mar'98Mar'97
Sales/Revenue331.88M278.42M259.48M230.57M204.96M173.34M173.1M160.9M155.14M143.9M122.17M123.62M118.51M112.3M110.02M91.19M81.06M75.42M70.45M66.47M60.47M55.31M53.32M57.18M66.78M75.57M79.97M69.7M78.5M47.3M
Revenue Growth %19.2%7.3%12.54%12.5%18.24%0.14%7.58%3.71%7.81%17.79%-1.18%4.32%5.53%2.07%20.65%12.49%7.48%7.05%5.99%9.93%9.34%3.73%-6.76%-14.38%-11.63%-5.5%14.73%-11.21%65.96%23.18%
Cost of Goods Sold223.57M188.97M175.68M162.21M146.52M127.22M130.62M121.56M117.7M108.93M93.05M94.54M88.72M84.89M82.9M67.89M61.77M56.67M51.91M49.78M45.37M41.41M39.92M43.9M49.14M47.98M52.98M43.4M50.7M27.7M
COGS % of Revenue67.37%67.87%67.7%70.35%71.49%73.39%75.46%75.55%75.87%75.7%76.16%76.47%74.86%75.6%75.35%74.45%76.2%75.14%73.68%74.89%75.03%74.88%74.87%76.77%73.58%63.5%66.25%62.27%64.59%58.56%
Gross Profit108.3M89.45M83.81M68.36M58.44M46.12M42.48M39.34M37.44M34.97M29.12M29.09M29.79M27.4M27.12M23.3M19.29M18.75M18.54M16.69M15.1M13.89M13.4M13.29M17.64M27.58M26.99M26.3M27.8M19.6M
Gross Margin %32.63%32.13%32.3%29.65%28.51%26.61%24.54%24.45%24.13%24.3%23.84%23.53%25.14%24.4%24.65%25.55%23.8%24.86%26.32%25.11%24.97%25.12%25.13%23.23%26.42%36.5%33.75%37.73%35.41%41.44%
Gross Profit Growth %21.07%6.74%22.6%16.97%26.72%8.57%7.97%5.08%7.07%20.09%0.11%-2.36%8.71%1.03%16.42%20.75%2.91%1.12%11.09%10.54%8.69%3.69%0.84%-24.7%-36.04%2.21%2.62%-5.4%41.84%35.17%
Operating Expenses95.04M71.58M64.03M52.11M44.3M35.05M31.63M29.11M28.41M27.04M22.82M22.32M23.09M21.46M21.7M18.71M16.91M16.06M15.26M14.34M13.58M12.99M13.09M12.85M23.65M24.63M26.87M22.5M23.6M16.2M
OpEx % of Revenue28.64%25.71%24.67%22.6%21.61%20.22%18.27%18.09%18.32%18.79%18.68%18.05%19.48%19.11%19.72%20.52%20.86%21.3%21.66%21.57%22.46%23.49%24.55%22.48%35.41%32.6%33.6%32.28%30.06%34.25%
Selling, General & Admin95.04M71.58M64.03M52.11M44.3M35.05M31.63M29.11M28.41M27.04M22.82M22.32M23.09M21.46M21.7M18.71M16.91M16.06M15.26M14.34M13.58M12.99M13.09M12.85M18.24M18.92M20.55M17.8M19.2M13.6M
SG&A % of Revenue28.64%25.71%24.67%22.6%21.61%20.22%18.27%18.09%18.32%18.79%18.68%18.05%19.48%19.11%19.72%20.52%20.86%21.3%21.66%21.57%22.46%23.49%24.55%22.48%27.31%25.04%25.69%25.54%24.46%28.75%
Research & Development000000000000000000000000901K1.17M1.51M1.6M1.7M1.6M
R&D % of Revenue------------------------1.35%1.54%1.89%2.3%2.17%3.38%
Other Operating Expenses0000000000000000000000004.51M4.55M4.81M3.1M2.7M1M
Operating Income13.26M17.87M19.78M16.25M14.14M11.07M10.85M10.23M9.03M7.93M6.3M6.77M6.71M5.95M5.43M4.59M2.38M2.69M3.28M3.89M1.52M899K307K434K-6M2.95M121.39K3.8M4.2M3.4M
Operating Margin %4%6.42%7.62%7.05%6.9%6.39%6.27%6.36%5.82%5.51%5.16%5.47%5.66%5.29%4.93%5.03%2.94%3.56%4.66%5.86%2.51%1.63%0.58%0.76%-8.99%3.91%0.15%5.45%5.35%7.19%
Operating Income Growth %-25.8%-9.64%21.74%14.88%27.73%2.06%6.07%13.33%13.76%25.9%-6.89%0.94%12.76%9.54%18.33%92.65%-11.36%-18.18%-15.67%156.46%68.85%192.83%-29.26%107.23%-303.45%2331.51%-96.81%-9.52%23.53%61.9%
EBITDA39.44M36.44M33.33M27.2M23.71M18.65M17.51M16.59M15.02M14.12M10.25M9.86M9.65M8.65M8.32M6.88M4.46M4.58M5.04M5.57M2.96M2.52M1.71M2.48M2.59M7.5M4.93M6.9M6.9M4.4M
EBITDA Margin %11.88%13.09%12.84%11.8%11.57%10.76%10.12%10.31%9.68%9.81%8.39%7.97%8.14%7.7%7.57%7.54%5.5%6.08%7.16%8.37%4.9%4.56%3.2%4.34%3.88%9.92%6.16%9.9%8.79%9.3%
EBITDA Growth %8.22%9.35%22.5%14.73%27.11%6.53%5.54%10.47%6.37%37.76%3.96%2.16%11.59%3.89%20.99%54.23%-2.66%-9.14%-9.39%87.76%17.66%47.8%-31.28%-4.17%-65.47%52.12%-28.57%0%56.82%69.23%
D&A (Non-Cash Add-back)26.17M18.57M13.54M10.96M9.57M7.58M6.66M6.36M5.99M6.18M3.95M3.09M2.94M2.7M2.9M2.29M2.08M1.9M1.76M1.67M1.45M1.62M1.4M2.05M8.59M4.55M4.81M3.1M2.7M1M
EBIT13.26M19.12M20.27M15.9M14M11.07M10.85M10.23M9.13M7.93M6.3M6.77M7M5.95M5.43M4.55M2.35M2.62M3.28M2.35M1.36M606K307K469K-6M2.95M121.39K3.8M4.1M3.4M
Net Interest Income-5.27M27K-1.03M-2.42M-810K-1.09M-1.12M-994K-1.08M-770K-295K-345K-259K-228K-182K-73K-63K-100K000000000000
Interest Income0825K808K00000000000-48K000000000000000
Interest Expense5.27M798K1.83M2.42M810K1.09M1.12M994K1.08M770K295K345K259K228K134K73K63K100K101K334K427K350K434K615K000000
Other Income/Expense-5.27M452K-1.34M-2.76M-953K-1.09M-1.12M-994K-1.08M-770K-295K-345K-259K-228K-182K-105K-98K-167K-538K-617K-589K-643K-146K915K-1.23M-2.52M-2.93M-2.1M-2.5M-100K
Pretax Income7.99M18.33M18.44M13.49M13.19M9.98M9.73M9.23M7.95M7.16M6.01M6.42M6.45M5.72M5.25M4.48M2.28M2.52M2.75M3.28M929K256K161K1.35M-7.23M428.74K-2.81M1.7M1.6M3.3M
Pretax Margin %2.41%6.58%7.11%5.85%6.44%5.76%5.62%5.74%5.12%4.98%4.92%5.2%5.44%5.09%4.77%4.92%2.82%3.34%3.9%4.93%1.54%0.46%0.3%2.36%-10.83%0.57%-3.51%2.44%2.04%6.98%
Income Tax2.61M3.81M4.79M2.8M1.81M2.19M1.66M2.09M2.03M2.64M1.88M2.4M2.46M2.01M1.94M1.69M832K963K382K1.22M-2.65M0-192K-408K-600K-84.4K-319K700K600K1.2M
Effective Tax Rate %32.71%20.8%25.99%20.75%13.72%21.95%17.09%22.63%25.49%36.88%31.35%37.32%38.19%35.22%37.06%37.8%36.44%38.23%13.92%37.15%-285.04%0%-119.25%-30.24%8.3%-19.69%11.36%41.18%37.5%36.36%
Net Income5.38M14.52M13.65M10.69M11.38M7.79M8.07M7.14M5.92M4.52M4.12M4.03M3.98M3.7M3.3M2.79M1.45M1.56M2.36M2.06M3.58M256K353K-4.71M-6.63M513.14K-2.49M1M1M2.1M
Net Margin %1.62%5.21%5.26%4.64%5.55%4.49%4.66%4.44%3.82%3.14%3.38%3.26%3.36%3.3%3%3.06%1.79%2.06%3.35%3.1%5.92%0.46%0.66%-8.25%-9.93%0.68%-3.11%1.43%1.27%4.44%
Net Income Growth %-62.96%6.36%27.69%-6.08%46.07%-3.42%12.9%20.65%30.96%9.65%2.43%1.05%7.56%12.17%18.44%92.14%-6.75%-34.15%14.76%-42.44%1297.27%-27.48%107.49%28.89%-1392.23%120.61%-349.01%0%-52.38%75%
Net Income (Continuing)5.38M14.52M13.65M10.69M11.38M7.79M8.07M7.14M5.92M4.52M4.12M4.03M3.98M3.7M3.3M2.79M1.45M1.56M2.36M2.06M3.58M256K353K1.76M-6.63M513.14K-2.49M1M1M2.1M
Discontinued Operations000000000000000000000000000000
Minority Interest000000000000000000000000000000
EPS (Diluted)0.571.571.631.401.501.031.080.950.810.640.580.570.540.490.430.370.190.210.320.280.500.040.05-0.77-1.090.09-0.410.160.160.33
EPS Growth %-63.69%-3.68%16.43%-6.67%45.63%-4.63%13.68%17.28%26.56%10.34%1.75%5.56%10.2%13.95%16.22%94.74%-9.52%-34.38%14.29%-44%1262.4%-29.29%106.74%29.36%-1311.11%121.95%-356.25%0%-51.52%37.5%
EPS (Basic)0.581.581.661.421.521.051.100.990.830.650.600.590.560.500.450.380.200.210.330.300.540.040.06-0.77-1.090.09-0.420.170.170.34
Diluted Shares Outstanding9.33M9.25M8.35M7.64M7.59M7.55M7.49M7.51M7.3M7.11M7.12M7.06M7.36M7.59M7.65M7.52M7.55M7.47M7.27M7.33M7.18M6.97M6.81M6.15M6.1M5.7M6.02M6.25M6.25M6.27M
Basic Shares Outstanding9.33M9.19M8.24M7.55M7.5M7.42M7.33M7.2M7.12M6.99M6.89M6.8M7.08M7.4M7.31M7.29M7.35M7.3M7.13M6.91M6.65M6.4M5.88M6.15M6.1M5.7M5.88M5.85M5.88M6.09M
Dividend Payout Ratio------------------------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Operating margin compression risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q4)

Revenue Growth Outpacing Operational Efficiency

According to recent quarterly filings, Transcat achieved a 15.8% year-over-year revenue growth in 2025Q4, signaling robust demand for its calibration services, yet this top-line expansion has failed to translate into consistent bottom-line growth, as evidenced by the significant volatility in quarterly earnings per share figures.

The consistent double-digit revenue growth suggests that Transcat is successfully capturing market share within the life sciences sector. However, investors should monitor whether this growth is organic or driven by acquisition-heavy capital deployment, as the lack of corresponding margin expansion implies that the company is struggling to achieve meaningful economies of scale.

Structural Margin Pressure Remains Persistent

As reported in financial statements, Transcat's operating margin has compressed to 3.6% in 2025Q4, reflecting a challenging cost environment where gross margins of 34.1% are insufficient to absorb rising SG&A expenses, which have consistently trended upward over the last ten quarters of reported operational data.

The persistent gap between gross and operating margins suggests that the company's hub-and-spoke laboratory model carries a high fixed-cost burden that is not scaling efficiently. This indicates that management may be facing difficulty in optimizing technician utilization rates, which are critical for maintaining profitability in a labor-intensive service business.

SG&A Burden Obscures Operational Gains

Based on the company's historical income statements, SG&A expenses have risen to $27.6M in 2025Q4, a significant increase from $14.8M in 2023Q4, suggesting that the costs associated with integrating acquisitions and maintaining a specialized workforce are currently outpacing the company's ability to generate incremental operating income.

The sharp rise in SG&A relative to revenue growth warrants further investigation into whether these costs are truly one-time integration expenses or a permanent shift in the company's operating cost structure. If these expenses remain elevated, the company's ability to achieve long-term margin expansion appears increasingly limited.

Earnings Volatility Masks Underlying Performance

Data from recent income statements indicates that net income has fluctuated significantly, dropping to $1.9M in 2025Q4 from $6.9M in 2023Q4, a trend that appears heavily influenced by non-operating items and inconsistent stock-based compensation charges that complicate the assessment of true recurring profitability for shareholders.

The volatility in net income suggests that investors should focus on adjusted metrics to better understand the company's core operational health. The impact of stock-based compensation, which reached $3.9M in 2025Q3, further complicates the quality of reported earnings and suggests that dilution may be a recurring concern for long-term equity holders.

Scale Benefits Remain Unproven Narrative

While the company's growth strategy relies on the premise of achieving scale, the reported 2025Q4 operating margin of 3.6% suggests that the business model may be inherently limited by high variable labor costs, challenging the narrative that Transcat can significantly improve its profitability through further geographic expansion.

Short-sellers might focus on the fact that despite years of acquisition-led growth, the company has yet to demonstrate a clear path to margin expansion. This raises the risk that the company is merely trading revenue growth for lower-quality earnings, which may not be sustainable if the labor market for specialized metrologists continues to tighten.

TRNS — Frequently Asked Questions

Quick answers to the most common questions about buying TRNS stock.

What was Transcat, Inc.'s (TRNS) revenue in 2025?

For fiscal year 2025, Transcat, Inc. (TRNS) reported total revenue of $331.9M. This represents a 601.6% increase compared to $47.3M in 1996.

Is Transcat, Inc. (TRNS) profitable?

Transcat, Inc. (TRNS) is profitable, generating $5.4M in net income for the fiscal year ending 2025 with a net profit margin of 1.6%.

What is Transcat, Inc.'s operating profit margin?

Transcat, Inc. (TRNS) reported an operating income of $13.3M, resulting in an operating profit margin of 4.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Transcat, Inc.'s gross profit and gross margin?

Transcat, Inc. (TRNS) generated $108.3M in gross profit for the year, representing a gross profit margin of 32.6%. This demonstrates the company's core pricing power and production efficiency.